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Abstract 
Different household insecticide applications via two electric vaporizers emitting transfluthrin were realized in a 
full-scale experimental room under controlled air exchange rate conditions. On-line high-time resolved 
measurements of the gas-phase concentrations of the active substance during and immediately after the 
spreading periods were performed with a High Sensitivity Proton-Transfer-Reaction Mass Spectrometer (HS-
PTR-MS). Experimental and modelled data from the ConsExpo 4.0 software were also compared to evaluate the 
sources of differences. Different application scenarios were also compared. Averaged inhaled concentrations 
over 1 h, 1 week, and 5 months were estimated to be 8.3, 1.8, and 1.8 µg.m−3, respectively. Corresponding 
margins of exposures range from 1000 to 10,000, claiming for the absence of effect. Dermal and dust ingestion 
pathways, although roughly estimated, seems being non-negligible. This claims for a more in-depth integrated 
risk assessment. 
Keywords: Exposure, Pyrethroid, Pesticide, Indoor, HS-PTR-MS 
 
1. Introduction 
The evaluation of indoor air contamination to environmentally-significant and health-relevant 
chemicals becomes a growing issue of concern, due to the current way of living that makes people 
spending more than 80% of their time in indoor environments (Schweizer et al., 2007). In this context, 
the increasing application of commercial household insecticides in indoor atmospheres is raising 
questions due to the potential hazardous properties of the active substances, since both exposure level 
and duration to those chemicals are likely to be significant. 
Among the existing active substances present in household insecticides, synthetic pyrethroids belong 
to the insecticide family most frequently applied today (Bekarian et al., 2006; Hahn et al., 2010) due 
to their low toxicity for mammals, compared to organochlorine or organophosphate analogues (CDC, 
2009). The use of pyrethroid insecticides is actually increasing for about ten years now (Horton et al., 
2010), especially via the application of electric vaporizers in France (Bouvier et al., 2006). Human 
toxicity of pyrethroid is considered as limited (Soderlund et al., 2002) due to rapid metabolic 
degradation of these compounds by hydrolysis, oxidation and conjugation reactions leading to water-
soluble metabolites that undergo urinary and biliary excretion (Leng et al., 1999). At levels below 
those inducing obvious signs of neurotoxicity (T-syndrome or CS-syndrome, Coats, 1990), several 
studies on animals however, show potential effects on neurodevelopment, reproduction and immune 
system after the exposure to some pyrethroids (ATSDR, 2003). Pyrethroid long-term effects on human 
health also still remain unclear (Feo et al., 2010; Kolaczinski and Curtis, 2004) but exposure to these 
compounds has nevertheless been shown to cause some adverse effects, especially for children and 
pregnant women (ATSDR, 2003). Pyrethroid exposure thus appears to cause neurotoxicity and 
developmental neurotoxicity (Shafer et al., 2005), as well as adverse effects on the immune system 
(Rosenberg et al., 1999). Besides, many studies reveal an increased risk of cancer due to pyrethroid 
exposure (Ila et al., 2008; Kocaman and Topaktaş, 2009; Shukla et al., 2002). More specifically, some 
pyrethroids were classified by the US EPA as possible human carcinogens (US EPA (2006a,b) RED 
reports for permethrin and cypermethrin). Finally, these molecules are suspected to be endocrine 
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disruptors (European Commission, 2004). Despite very frequent use of these insecticides in western 
countries (Bouvier et al., 2006; Grey et al., 2006), only very few studies deal with the concentration of 
insecticidal substances during and immediately after commercial household insecticide application 
(Berger-Preiss et al., 2009; Leva et al., 2009; Matoba et al., 2004; Nazimek et al., 2011; Pentamwa et 
al., 2011). 
Consequently, this study intends to evaluate the exposure to transfluthrin during the application of two 
electric vaporizers in a full-scale environmental test room. Few studies (Hahn et al., 2010; Whyatt et 
al., 2007) demonstrated that inhalation is one of the primary routes for residential pesticide exposure. 
For this reason a particular attention is given to the measurements of the concentrations of the gas-
phase and particulate phase in the indoor environment. An evaluation of the gas-phase concentration is 
also performed with the ConsExpo software in order to compare both experimental and modelling 
approach. Due to the suspected health effects of these molecules as well as the potential frequencies, 
levels and durations of exposure, the evaluation of the average inhaled concentrations for different 
durations during the application of household insecticide via electric vaporizers have been estimated to 
supplement existing long-term exposure data. 
 
2. Materials and methods 
2.1. Insecticide electric vaporizers 
Two commercial electric vaporizers (5 Welectric heating units) used for household treatment against 
mosquitoes were considered: “Raid® Electric — Fly & Mosquito Protector” and “Baygon® Genius 
Protector — Electric Liquid”. The active substance transfluthrin (CAS# 118712-89-3), a type I 
pyrethroid, is used in both commercial refills, under different formulations: solid pad refill or liquid 
mix refill. The active substance content (% w/w) and formulation are detailed in Table 1. 
 
2.2. Test room description and conditions of application 
Different application scenarios of the electric vaporizers (Table 1) were realized in the “Mechanised 
house for Advanced Research on Indoor Air” (MARIA) experimental house, at the Scientific and 
Technical Centre of Building (CSTB), Marne-la-Vallée, France (Ribéron and O'Kelly, 2002). The 
electric vaporizers were mounted on the supports and applied in an empty room (V = 32.3 m3) of 
MARIA house. The ceiling is concrete painted and walls are covered with patches of painted plaster. 
The temperature and relative humidity were continuously measured during the experiments. Air 
exchange rates (AERs) were kept constant, at 0.35 h−1 for experiments A and C and at 0.14 h−1 for 
experiment B (Table 1). 
Concerning the ventilation, the experimental air exchange rates (0.14 and 0.35 h−1) correspond to 
realistic worst-case conditions compared to residential ventilation conditions that typically range 
from1 to 0.5 h−1 for existing and new housing, respectively (Spengler et al., 2001). However, such 
ventilation conditions can be found in dwellings (Frederiksen et al., 2011) with defective mechanical 
ventilation systems (Lucas et al., 2009). More importantly, such low ventilation conditions especially 
occur during the night (Lucas et al., 2009) when electric vaporizers are supposed to be applied. 
The vaporizers were plugged in the centre of the room at a height of about 1 m above the floor level. 
The application lasted 8 h according to typical night duration. The concentration of the pesticide was 
monitored 1 h before the beginning of the spreading period (so-called “reference situation”), during 
the application (increase of concentration) and once the vaporiser was unplugged, until the 
concentration level becomes stable and close to the initial background level (elimination phase). The 
vaporizers were weighted before and after their application (Table 1), in order to determine the 
quantity of active substance emitted, accounting for the active ingredient mass content provided by the 
manufacturer (Table 1). For more details about the experimental conditions the readers are referred to 
Vesin et al. (2013). 
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2.3. Gas-phase transfluthrin measurements 
The household insecticide treatment exhibits high emission variability. Therefore, the measurements 
of the gaseous transfluthrin emitted by the electric vaporizer refills was performed with a High 
Sensitivity Proton-Transfer-Reaction Mass Spectrometer (HS-PTR-MS) (Ionicon Analytik), which 
provided on-line and high time-resolved measurements (Vesin et al., 2012). The HS-PTR-MS 
technique is based on chemical ionization of the molecules under study through H3O+ transfer 
reactions, combined with subsequent mass spectrometric ion detection (Lindinger et al., 1998). The 
instrument is composed of an ion source in which H3O+ are produced from pure water vapour with a 
hollow cathode, a drift tube where the proton transfer reactions between H3O+ and the molecules under 
study occur, and a quadrupole mass spectrometer, which differentiates the ions, according to their m/z, 
downstream coupled to a secondary electron multiplier detector for selective and sensitive detection. 
HS-PTR-MS calibration was realized through the generation of a standard gaseous flux of 
transfluthrin at constant temperature under continuous controlled nitrogen flow. During the room 
experiments, the HS-PTR-MS was operated under the experimental conditions adjusted during the 
calibration step (Vesin et al., 2012). 
 
2.4. Modelling of transfluthrin gas-particle partitioning 
Due to the relatively low vapour pressure of transfluthrin (4.12 × 10−4 Pa at 25 °C), this Semi-Volatile 
Organic Compound (SVOC) is likely to be distributed between the gas-phase and the different 
surfaces present in the indoor environment (i.e., airborne particles, settled dust, indoor surfaces). In 
order to evaluate the inhalation exposure following insecticide household application, the 
concentrations of transfluthrin in both the gas-phase and particulate phase ought to be considered. 
Particles of transfluthrin may actually arise due to nucleation or condensation processes that occur 
only if the saturated gas-phase concentration of transfluthrin (62 µg.m−3 at 25 °C) is reached. A SMPS 
(ScanningMobility Particle Sizer) (GrimmTechnik) device scanning particles ranging from 11.1 to 
1083.3 nm in diameter was used to observe eventual particle formation. 
Transfluthrin is likely to be adsorbed on airborne particles (suspended matter) being already present in 
the room. Transfluthrin equilibrium partitioning in the air compartment between the gas-phase and 
airborne particles was evaluated with the model developed by Weschler and Nazaroff (2008) that has 
been extended in Weschler and Nazaroff (2010) and Little et al. (2012) (details are provided in 
supplemental material). 
A modelling of the gas-phase concentration via the ConsExpo 4.0 software was also realized to enable 
a comparison with the experimental data. The model was run as a standard user would do it, only 
having basic information about electric vaporizer application, viz. the application duration (8 h), the 
volume of the room (32.3 m3), the commercial product amount spread in the room (µg), the weight 
fraction of active substance in the commercial product and the air exchange rate (% w/w) (Table 1). It 
was supposed that the pesticide is released with a constant rate during the application duration. 
 
Table 1: Characteristics of the vaporizers refills and conditions of application 
Exp. Active 
substance 
Commercial 
formulation 
Commercial 
brand 
Content 
(% w/w) 
AER 
(h-1) 
Mass of commercial 
product emitted during 
the 8h application (mg) 
A Transfluthrin Solid Raid® 13.4 0.35 18.44 
B Transfluthrin Solid Raid® 13.4 0.14 18.56 
C Transfluthrin Liquid Baygon® 0.88 0.35 463.06 
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2.5. Exposure assessment 
As suggested by the US EPA (1992), the exposure over a period of time is assessed according to the 
Eq. (1): 
∫=
2
1
)(t
ti
dttCE
                     (1) 
where Ei is the magnitude of the exposure during the application i (µg.m−3), C(t) is the concentration 
as a function of time (µg.m−3), t is time (h), t2 − t1 being the exposure duration (h). 
The exposure duration depends on the simulated exposure. However, there is currently a significant 
lack with respect the usage scenarios of household insecticides in Europe. Consumer habits and 
behaviours are actually most of the time unknown and are likely to vary a lot from a country to 
another. In the context of the Directive 98/8/EC, (1998, 2010) concerning the placing of biocidal 
products on the market, the dossier of evaluation of transfluthrin as product-type 18 assumes a 5 
months per year daily exposure to evaluate the exposure arising from the application of electric 
vaporizers (CAR, 2010). The ConsExpo factsheet (Bremmer et al., 2006) as well as the study of Hahn 
et al. (2010) assumed the same frequency of application for electric vaporizers. Their working time is 
assumed to be of 8 h per day of application, in bedrooms when people are asleep (Bremmer et al., 
2006). During the other period of time it was considered that people are not present in the room and 
thus not exposed. Accordingly we chose 5 months per year of 8 h daily exposure. 
The exposure durations were set to 1 h and 1 week for acute exposures and 5 months for subchronic 
exposures. 
 
3. Results and discussion 
3.1. Concentrations of transfluthrin in the gas-phase 
The transfluthrin gas-phase concentration profiles for the different experiments (Fig. 1 for experiment 
C) show a rapid increase as soon as the electric vaporizer is plugged in and reach a peak a few minutes 
after unplugging. The active ingredient concentration then starts decreasing, to finally reach a 
concentration close to the initial background level in several hours. 
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Figure 1: Concentration time profile of gaseous transfluthrin during and after vaporizer application for Experiment C. 
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Transfluthrin peak concentrations range from 4.9(±0.8) µg.m−3 for the solid refill of transfluthrin with 
an AER of 0.35 h−1 (Exp. A) to 8.5(±0.6) µg.m−3 for the same refill with an AER of 0.14 h−1 (Exp. B) 
(Table 2). For comparison, the background pyrethroid concentrations found in homes sometimes reach 
several dozens of ng.m−3 with very diverse values depending on the homes and the pesticide 
substances (Clayton et al., 2003; Morgan et al., 2007; Pang et al., 2002; Wilson et al., 2010). Thus, 
trans-permethrin is often found to have the highest indoor air concentration (gas-phase + airborne 
particles), with maximums ranging from several ng.m−3 (6.8 ng.m−3 for Morgan et al., 2007, 11 ng.m−3 
for Bradman et al., 2007) to more than one hundred of ng.m−3 (130 ng.m−3 for Tulve et al., 2008 and 
164 ng.m−3 for Whyatt et al., 2007). In some homes, the background trans-permethrin concentration is 
on the contrary very low, below the limit of quantification, ranging from 0.1 to 0.8 ng.m−3 (Morgan et 
al., 2007; Whyatt et al., 2002). Cypermethrin is found to have maximum indoor air background 
concentrations (gas-phase + airborne particles) ranging between 100 and 380 ng.m−3 (Bradman and 
Whyatt, 2005; Tulve et al., 2008). Compared to these concentrations typically found in indoor air, the 
pyrethroid exposure peak levels measured in the gas-phase during the spreading periods therefore turn 
out to be from 10 to 1000 time higher. Moreover, compared to the present measurements, the few 
literature data (Berger-Preiss et al., 2009; Class and Kintrup, 1991; Nazimek et al., 2011) concerning 
pyrethroid concentrations during application of electric vaporizers in indoor environments show 
similar concentrations, ranging from 0.4 to 12 µg.m−3. 
 
Table 2: Peak concentrations determined via the HS-PTR-MS experimental measurements (gaseous phase) and the ConsExpo 
model 
Exp. 
Measured peak 
concentration  
(µg.m-3) 
ConsExpo peak 
concentration 
(µg.m-3) 
A 4.9±0.8 25.6 
B 8.5±0.6 45.7 
C 5.6±0.5 42.2 
 
No significant formation of particles was observed with the SMPS device during the application of the 
electric vaporizers. However, the background concentration of PM1 airborne particles was detected 
around 10(±2) µg.m−3. As a result, these particles can serve as a support for adsorption of transfluthrin 
and become another exposure medium in the air compartment in addition to gaseous transfluthrin. 
According to Eq. (S3), the transfluthrin proportion being absorbed on PM1 airborne particles is found 
to be around 0.11% relative to the quantity present in the gas-phase. Consequently, nearly the totality 
of transfluthrin being present in the air compartment is found in the gas-phase. 
In addition, we compared the experimental data to those modeled with the ConsExpo 4.0 software 
(Fig. 1), largely used for exposure evaluations to consumer products (Hahn et al., 2010). This 
comparison shows that the peak concentrations evaluated by ConsExpo (Table 2) are much higher 
than the measured concentrations. The ConsExpo modelling of concentration therefore proves not to 
be in compliance with the concentration which is actually present in the room. This difference between 
experimental and modelled data can be explained by the fact that a large proportion of emitted 
transfluthrin is directly adsorbed on the different surfaces (walls, soil, ceiling, dust, suspended 
particles). According to the model of Weschler and Nazaroff (2008, 2010) and considering the 
available surfaces of the test room, the proportion of transfluthrin assumed to be adsorbed on those 
indoor surfaces is actually evaluated to be around 90% (Details for the partition modelling are 
provided in supplemental information). This large proportion of transfluthrin being adsorbed on room 
surfaces is moreover confirmed by a mass balance calculation realized in Vesin et al. (2013). This 
mass balance evaluation on the present dataset actually showed an 81%- to 86%-deviation between the 
concentration that should have theoretically been present in the room considering the quantity that was 
spread by the electric vaporizers, and the transfluthrin gas-phase concentration that was actually 
measured by the HS-PTR-MS. The theoretical transfluthrin concentration was calculated on the basis 
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of the weighing of the refills before and after the experiments. Finally, several authors find agreeing 
results about deposition of household pyrethroids on various indoor surfaces (Classand Kintrup, 
1991;Matoba et al., 2004; Pentamwa et al., 2011). The differences observed between the experimental 
data and the ConsExpo modelling are therefore due to the large proportion of transfluthrin being 
adsorbed on surfaces, since the ConsExpo model does not take into account these sorption effects 
(Delmaar et al., 2005), which can however considerably lower the gas-phase transfluthrin 
concentration, due to its semi volatile nature. 
Based on the mass emission rates (ER, µg.h−1) determined in Vesin et al. (2013) for the three 
experiments (Table 1), different application scenarios are then built to evaluate the influence of 
emission conditions on the gas-phase transfluthrin concentration. Assuming that ventilation is the only 
elimination mechanism occurring in the air compartment, the increasing gas-phase concentration 
profile during the spreading of pesticide is governed by the following Eq. (2): 
)1(
.
)( .tk
AER
R
g
AERe
Vk
E
tC −−+=
        (2) 
where t is the time (h), Cg(t) is the gas-phase concentration of transfluthrin in the room (µg.m−3), kAER 
is the air exchange rate constant (h−1), ER is the mass emission rate of the vaporizer (µg.h−1) and V is 
the volume of the chamber and of the sampling tubing (m3) (V = 32.3 m3 + 0.35 m3). 
The influence of ventilation is tested by applying different air exchange rates, of 0.14 h−1, 0.35 h−1, 0.5 
h−1 and 1.0 h−1 respectively. Thus, the realistic worst-case conditions applied during experiments to 
simulate poor aeration during the night (kAER = 0.14 h−1 and 0.35 h−1) are compared to the typical 
residential ventilation conditions ranging from 0.5 h−1 to 1.0 h−1. In addition, the influence of the 
spreading duration is investigated by modelling the gas-phase concentrations for an 8-hour emission to 
simulate the case of a normal and recommended application. Finally, a 24-hour emission was tested to 
model the case of longer application periods such as forgotten electric vaporizers plugged in all day 
long (Fig. 2). 
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Figure 2: Modelled gaseous concentration profiles of transfluthrin for different application scenarios based on Experiment C. 
 
The resulting peak concentration ranges for the different experiments after 8-hour and 24-hour 
emissions respectively, are displayed in Table 3, as well as the steady-state concentrations and the 
emission duration needed to reach the steady-state maximum concentrations.  
According to Table 3 and Fig. 2, the lower is the AER, the higher are the concentrations at the end of 
pesticide application (8-hour and 24-hour emissions). A similar trend is also observed for the steady-
state maximum concentrations. Moreover, these modelled data show that in the case of an overdose 
application (24-hour spreading), low AER values (here 0.14 h−1) lead to significantly higher 
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concentrations compared to an 8-hour emission. In the case the electric vaporizer has been forgotten to 
plug into a poorly ventilated room, the resulting exposure concentrations are therefore higher. On the 
contrary, the data reveal that in the case of a correct ventilation (AER of 0.5 and 1.0 h−1, and even for 
an AER of 0.35 h−1), the gas-phase concentrations are similar for an 8-hour and a 24-hour emission. In 
other words, a correct AER prevents a significant increase of pesticide concentration in indoor 
atmosphere. Therefore, the air exchange rate appears to be a crucial parameter controlling the 
concentrations levels of the pesticide indoors. In the case of insufficient ventilation, the spreading 
duration also plays a significant role regarding the gas-phase exposure concentrations that can be 
increase of 40% for the 0.14 h−1 AER condition between an 8-hour and a 24-hour application. 
 
Table 3: Modelled gaseous concentration ranges for different application scenarios (AER and emission duration) 
AER 
(h-1) 
Concentration after 
8 h emission 
(µg.m-3) 
Concentration after 
24 h emission 
(µg.m-3) 
Steady-state 
concentration 
(µg.m-3) 
Time to reach steady-
state concentration 
(within 1%) (h) 
0.14 8.1-11.0 11.5-15.7 11.9-16.4 32.9 
0.35 4.5-6.1 4.8-6.5 4.8-6.5 13.2 
0.5 3.3-4.5 3.3-4.6 3.3-4.6 9.2 
1 1.7-2.3 1.7-2.3 1.7-2.3 4.6 
 
3.2. Exposure assessment 
The inhalation exposure to transfluthrin corresponds to the inhaled concentration (µg.m−3) and depends 
on its concentration in all the media that are in contact with the lung. This is the case for both the gas-
phase and the particulate phase (for the smaller particles). Because of the very small proportion of 
transfluthrin being present under the particulate phase (<0.11%, see Section 3.1), the exposure via the 
inhalation of particles was neglected. 
The inhaled concentrations averaged over 1 h, 1 week and 5 months are presented in Table 4 for the 
lowest AER (0.14 h−1). The mean inhaled concentrations integrated over 1 h of vaporizer use (in the 
area of the maximal concentration measured), 1 week and 5 months with an 8 h per day use of the 
vaporizer (during the plugging), are 8.3, 1.8 and 1.8 µg.m−3, respectively. These integrated inhaled 
concentrations correspond to a realistic exposure scenario (1 h of exposure around the peak during the 
night, 1 week of exposure or several months during the blood-feeding period of mosquitoes). These 
inhaled concentrations could be directly compared with toxicity indicators obtained in toxicological 
studies (no observed adverse effect levels, NOAELs) in order to determine amargin of exposure (i.e., 
the ratio between human exposure and NOAELs obtained in animal toxicity testing). For inhalation 
exposures, the respiratory and central nervous systems appear to be the main targets of transfluthrin. 
Mice were exposed by inhalation during 45 min to an aerosol (94.5% pure) of transfluthrin. A 
respiratory rate reduction was observed at 46 mg.m−3 leading to define a NOAEL at 11 mg.m−3 (ACP, 
1997). In the first public version of Competent Authority Report for transfluthrin (CAR, 2010), a 
NOAEL of 15 mg.m−3 was identified after a daily inhalation exposure (6.5 h per day) of pups from 
postnatal days 10 to 16 (6 days) in mammals, based on an increase in muscarinic receptor levels in the 
brain cortex at day 17. Thus the lowest NOAEL at 11 mg.m−3 could be used for acute (1 h) to subacute 
(several days, 1 week) exposure duration. In subchronic toxicity studies (28 and 90 days), NOAELs 
between 36 and 46 mg.m−3 were identified after daily inhalation exposures (6 h per day, 5 days per 
week) of rats, based on minor clinical chemistry changes at 168 mg.m−3 and tremors, increased 
motility and bristling or ungroomed coats at 220 mg.m−3 (ACP, 1997). The lowest NOAEL at 36 
mg.m−3 could be used for a 5-month exposure duration in human. After a temporal adjustment (×6 h/8 
h and ×5 days/7 days), the NOAEL becomes 19 mg.m−3. There are no chronic toxicological studies. 
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Table 4: 1-hour, 1-week and 5-month inhalation exposure to transfluthrin and corresponding margins of exposure, during the 
use 8 h per day of an electric vaporizer with low (0.14 h-1) air exchange rate. 
Exposure 
duration 
Average inhaled 
concentration (µg.m-3) 
NOAEL 
(µg.m-3) 
Margin of 
exposure 
1 h 8.3 11 000 1 300 
1 week 1.8 11 000 6 100 
5 months 1.8 19 000 10 500 
 
As indicated in Table 4, margins of exposure range from 1300 to 10,500, indicating that adverse 
effects are not likely to occur (the decision threshold could vary from 100 to 1000 according to the 
availability of toxicity data) (US EPA, 1993). No margin of exposure could be calculated for chronic 
exposures in the absence of NOAEL. In the case of the 1 h exposure duration, the margin of exposure 
is close to the decision threshold (1300 versus 1000) derived from the NOAEL obtained in the sensory 
irritation study. If no adverse effects are theoretically expected, it would probably be relevant to 
consider a more-in-depth evaluation. These should include multipathways and multi compounds 
approach. 
Although other exposure pathways can occur, as published for other pyrethroid, for instance 
permethrin (Zartarian et al., 2012), this first tier evaluation was limited to inhalation. Regarding their 
specific time–activity pattern, including crawling on the floor and hand-to-mouth contact, children are 
likely to be exposed to the active substance through other exposure routes such as dermal contact with 
air and surfaces (floor especially) and ingestion of settled dust. Due to the high concentrations that are 
likely to be present on the room surfaces (Vesin et al., 2013) and in dust, the evaluation of the 
ingestion and dermal intakes (in µg of substance per day) could therefore be relevant to get evaluation 
of the total exposure. 
Considering the ingestion route, on the basis of a log(KOA) for transfluthrin equal to 8.43 (Vesin et al., 
2012) and of a transfluthrin concentration in the gas-phase of 1.8 µg.m−3 (averaged inhaled 
concentration for 8 h), themass fraction of transfluthrin in dust can be estimated to 48.4 µg.g−1 
according to the SVOC partitioning model between the gas-phase and the settled dust (Weschler and 
Nazaroff, 2010). Using a mean dust intake rate of 60 mg.day−1 for a child (US EPA, 2011), we can 
calculate that mean intake via dust ingestion would be equal to 2.9 µg.day−1. Breathing 8.9 m3.day−1 
(for a 2–3 years child) of air containing 1.8 µg.m−3 of transfluthrin leads to an inhalation intake of 16 
µg.day−1. Inhalation intake is thus expected to be more than 5 times higher than ingestion one (details 
of ingestion exposure are provided in supplemental material). 
Dermal intake is difficult to assess due to methodological difficulties and would fall beyond the scope 
of this paper. However it seems possible to assess relative importance of inhalation and dermal 
pathway to exposure, based on the framework recently proposed by Weschler and Nazaroff (2012), on 
the basis of chemical properties of SVOCs. Considering the chemical characteristics of transfluthrin 
(Vesin et al., 2012), application of this model leads to expect a dermal intake of the same order of 
magnitude than inhalation one (details of dermal route intake comparison with inhalation one are 
provided in supplemental material). 
To sum up, dermal pathway is expected to double inhalation exposure whereas ingestion is expected to 
add 20%. This reinforces the need for a more in-depth integrated risk assessment. This work moreover 
shows the necessity of carefully evaluating chronic exposure to those types of chemicals that may 
cause health effects on the long term. Moreover, due to the significant proportion of transfluthrin 
being adsorbed on indoor surfaces, they can act as a secondary source of emission, because of the 
reversible nature of the adsorption mechanism and generate long-term and low pollution source of 
insecticide.  
Finally, a cumulative approach considering other substances with similar mode of action and similar 
properties to transfluthrin (sensory irritations, neurodevelopmental effects) would be a perspective to 
this first tier of risk assessment of transfluthrin electric vaporization. 
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